CCP, cyclic citrullinated peptide

Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis
B Vander Cruyssen, I E A Hoffman, H Zmierczak, M Van den Berghe, E Kruithof, L De Rycke, H Mielants, E M Veys, D Baeten, F De Keyser

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1145-1149; DOI: 10.1136/ard.2004.032177
High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities
M van Oosterhout, R J Verburg, E W N Levarht, J D Moolenburgh, R M Barge, W E Fibbe, J M van Laar

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1783-1785; DOI: 10.1136/ard.2004.034793
Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis
M M J Nielen, A R van der Horst, D van Schaardenburg, I E van der Horst-Bruinsma, R J van de Stadt, L Aarden, B A C Dijkmans, D Hamann

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1199-1204; DOI: 10.1136/ard.2004.029389
Ectopic lymphoid neogenesis in psoriatic arthritis
Juan D Cañete, Begoña Santiago, Tineke Cantaert, Raimon Sanmartí, Antonio Palacin, Raquel Celis, Eduard Graell, Beatriz Gil-Torregrosa, Dominique Baeten, José L Pablos

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 720-726; DOI: 10.1136/ard.2006.062042
Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)
A Kastbom, G Strandberg, A Lindroos, T Skogh

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1085-1089; DOI: 10.1136/ard.2003.016808
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
C Alessandri, M Bombardieri, N Papa, M Cinquini, L Magrini, A Tincani, G Valesini

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1218-1221; DOI: 10.1136/ard.2003.014647
Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey
D Aletaha, G Eberl, V P K Nell, K P Machold, J S Smolen

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1269-1275; DOI: 10.1136/ard.2003.015131
Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study
J van Aken, H van Dongen, S le Cessie, C F Allaart, F C Breedveld, T W J Huizinga

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 20-25; DOI: 10.1136/ard.2005.038471
The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
H A Chen, K C Lin, C H Chen, H T Liao, H P Wang, H N Chang, C Y Tsai, C T Chou

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 35-39; DOI: 10.1136/ard.2005.038851
Influence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population
D Ligeiro, J E Fonseca, O Abade, I Abreu, M Cruz, P Nero, J Cavaleiro, J Teles, H Trindade, J M Caetano, J Branco

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 246-248; DOI: 10.1136/ard.2005.051177

Log in using your username and password

Main menu

Log in using your username and password

You are here

CCP, cyclic citrullinated peptide